An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS
- Conditions
- HIV/AIDS
- Registration Number
- NCT03738410
- Lead Sponsor
- University of Miami
- Brief Summary
The purpose of this study is:
1. To develop a new mobile health (mHealth) system that will send text messages to remind both pregnant and non-pregnant women with HIV to adhere to their treatment plan (like keeping appointments, fillings prescriptions, and taking their medication) and address individual barriers to HIV care (like stigma, medical mistrust and resilience).
2. The intervention will also include patient navigation and motivational interviewing
2) Investigators also want to see if the mHealth system is feasible, easily accepted and if it will impact patient health in a positive way.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 80
- Confirmed HIV diagnosis as per the clinic standard
- Female >= 18 years old at enrollment
- Currently active or recently returned into care or newly enrolled
- With two or more previously scheduled visits (12 months prior to study enrollment
- in the 12 months prior to enrollment:
- missed one or more visits or
- viral load detectable (>20 mL) or
- not taking prescribed HIV anti-retroviral medications
- men
- women who are cognitively impaired or are not able to consent for themselves
- non-working cell phone
- adolescents < 18 years old at enrollment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Primary Outcome Measures
Name Time Method Rate of Enrollment Month 12 The proportion of participants enrolled and proportion of participants declined enrollment or screen failed out of total number of participants approached.
Acceptability of the mHealth application Month 12 The proportion of messages opened, which were received
- Secondary Outcome Measures
Name Time Method Change in HIV Stigma Baseline, Month 12 Change in measured stigma (AIDS-related Stigma Scale) within 12 months of randomization (range 40=strongly disagree to 160=strongly agree).
Change in Medical Mistrust Baseline, Month 12 Change in measured medical mistrust (Group-based Medical Mistrust) within 12 months of randomization (range 12=does not agree at all to 60=completely agrees).
Change in Resilience Baseline, Month 12 Change in measured resiliency (Connor-Davidson Resiliency Scale) within 12 months of randomization (range 0=not true at all to 100=true nearly all of the time).
Change in Clinic Attendance Baseline, Month 12 Change in attendance to HIV primary care visits within 12 months of randomization
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
University of Miami
🇺🇸Miami, Florida, United States
University of Miami🇺🇸Miami, Florida, United StatesWilmar D Mondestin, M.S.Contact305-243-5800wbelizaire@med.miami.eduLunthita M Duthely, Ed.D.Principal Investigator